Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. MYND Lifesciencs Inc.
  6. News
  7. Summary
    MYND   CA62857B1094

MYND LIFESCIENCS INC.

(MYND)
SummaryQuotesChartsNewsCompanyFinancials 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about MYND LIFESCIENCS INC.
01/12MYND Lifesciencs Inc. Announces Resignation of Jordan Cleland as Chief Operating Office..
CI
01/12Mynd Life Sciences Announces Collaborative Research Agreement with the University of Br..
CI
2021MYND Lifesciencs Inc. Provides Update on Depression Gene Modulation Pathway Patent Appl..
CI
2021MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
AQ
2021MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test
AQ
2021MYND Diagnostics Inc. Commences Clinical Research on Multiple Sclerosis Biomarker Test
CI
2021MYND Lifesciencs Inc. Announces Board and Audit Committee Changes
CI
2021MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Tre..
CI
2021MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidi..
CI
2021MYND LIFE SCIENCES INC : . Announces RSU Grant
AQ
2021MYND Lifesciencs Inc. announced that it has received CAD 2.7 million in funding
CI
2021MYND LIFESCIENCS : Life Sciences Announces $3 Million Convertible Debenture Unit Offering
AQ
2021MYND Lifesciencs Inc. announced that it expects to receive CAD 3 million in funding
CI
2021MYND LIFESCIENCS : Life Sciences Announces DTC Eligibility
AQ
2021MYND Life Sciences Expands Intellectual Portfolio to Target Alzheimer's disease
CI
More most relevant news
All news about MYND LIFESCIENCS INC.
01/12MYND Lifesciencs Inc. Announces Resignation of Jordan Cleland as Chief Operating Office..
CI
01/12Mynd Life Sciences Announces Collaborative Research Agreement with the University of Br..
CI
2021MYND Lifesciencs Inc. Provides Update on Depression Gene Modulation Pathway Patent Appl..
CI
2021MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
AQ
2021MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test
AQ
2021MYND Diagnostics Inc. Commences Clinical Research on Multiple Sclerosis Biomarker Test
CI
2021MYND Lifesciencs Inc. Announces Board and Audit Committee Changes
CI
2021MYND Life Sciences Signs Agreement to Acquire Rights for the Use of Psychedelics to Tre..
CI
2021KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie..
AQ
2021KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
AQ
More news
News in other languages on MYND LIFESCIENCS INC.
01/12MYND Lifesciencs Inc. annonce la démission de Jordan Cleland au poste de directeur de l..
01/12Mynd Life Sciences annonce un accord de recherche en collaboration avec l'Université de..
More news
Press releases
2021MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
AQ
2021MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test
AQ
2021KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Vie..
AQ
2021KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th
AQ
2021MYND LIFE SCIENCES INC : . Announces RSU Grant
AQ
More press releases